MXPA05007462A - Derivados de pirrolopiridazina. - Google Patents

Derivados de pirrolopiridazina.

Info

Publication number
MXPA05007462A
MXPA05007462A MXPA05007462A MXPA05007462A MXPA05007462A MX PA05007462 A MXPA05007462 A MX PA05007462A MX PA05007462 A MXPA05007462 A MX PA05007462A MX PA05007462 A MXPA05007462 A MX PA05007462A MX PA05007462 A MXPA05007462 A MX PA05007462A
Authority
MX
Mexico
Prior art keywords
pyrrolopyridazine derivatives
pyrrolopyridazine
derivatives
pde
tnf
Prior art date
Application number
MXPA05007462A
Other languages
English (en)
Inventor
Kenichiro Imamura
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2003900189A external-priority patent/AU2003900189A0/en
Priority claimed from AU2003903628A external-priority patent/AU2003903628A0/en
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Publication of MXPA05007462A publication Critical patent/MXPA05007462A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

La invencion se relaciona con un compuesto de formula (I) o su sal, en el cual R1, R2, R3 y R4 son como se definen en la descripcion, su uso como un medicamento, el procedimiento para su preparacion y el uso para el tratamiento de enfermedades mediadas por PDE-IV o TNF-( (ver formula (I)).
MXPA05007462A 2003-01-09 2003-12-26 Derivados de pirrolopiridazina. MXPA05007462A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2003900189A AU2003900189A0 (en) 2003-01-09 2003-01-09 Heterocyclic derivatives
AU2003903628A AU2003903628A0 (en) 2003-07-14 2003-07-14 Pyrrolopyridazine derivatives
PCT/JP2003/017091 WO2004063197A1 (en) 2003-01-09 2003-12-26 Pyrrolopyridazine derivatives

Publications (1)

Publication Number Publication Date
MXPA05007462A true MXPA05007462A (es) 2006-01-27

Family

ID=32714072

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05007462A MXPA05007462A (es) 2003-01-09 2003-12-26 Derivados de pirrolopiridazina.

Country Status (22)

Country Link
US (2) US7153854B2 (es)
EP (1) EP1581535B3 (es)
JP (1) JP4671104B2 (es)
KR (1) KR101026819B1 (es)
AR (1) AR042833A1 (es)
AT (1) ATE376549T1 (es)
BR (1) BR0317358A (es)
CA (1) CA2513081C (es)
CY (1) CY1107084T1 (es)
DE (1) DE60317102T3 (es)
DK (1) DK1581535T5 (es)
ES (1) ES2291729T7 (es)
HK (1) HK1088900A1 (es)
IL (1) IL169500A0 (es)
MX (1) MXPA05007462A (es)
NO (1) NO20053748L (es)
NZ (1) NZ541232A (es)
PL (1) PL378245A1 (es)
PT (1) PT1581535E (es)
RU (1) RU2328499C2 (es)
TW (1) TWI332004B (es)
WO (1) WO2004063197A1 (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL378245A1 (pl) 2003-01-09 2006-03-20 Astellas Pharma Inc. Pochodne pirolopirydazyny
US7030112B2 (en) * 2003-03-25 2006-04-18 Bristol-Myers Squibb Company Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders
GB0411056D0 (en) 2004-05-18 2004-06-23 Novartis Ag Organic compounds
EP1763528B1 (en) * 2004-07-05 2008-11-26 Astellas Pharma Inc. Pyrazolopyridine derivatives
WO2006004191A1 (en) * 2004-07-05 2006-01-12 Astellas Pharma Inc. Pyrrolopyridazine derivatives which inhibit pde iv and tnf alfa
GB0422057D0 (en) * 2004-10-05 2004-11-03 Astrazeneca Ab Novel compounds
GB0601951D0 (en) 2006-01-31 2006-03-15 Novartis Ag Organic compounds
JP2010508315A (ja) 2006-10-30 2010-03-18 ノバルティス アーゲー 抗炎症剤としてのヘテロ環式化合物
JP2009114123A (ja) * 2007-11-06 2009-05-28 Astellas Pharma Inc ２−アシル−１−アミノピロール化合物の新規製造法
EP2674417A3 (en) * 2007-11-21 2014-04-09 Decode Genetics EHF Biaryl PDE4 inhibitors for treating inflammation
ES2442930T3 (es) 2008-01-11 2014-02-14 Novartis Ag Pirimidinas como inhibidores de cinasas
US20110105510A1 (en) * 2008-06-17 2011-05-05 Hiroshi Ishikawa Prophylactic/ameliorating or therapeutic agent for non-alcoholic steatohepatitis
CA2738429C (en) * 2008-09-26 2016-10-25 Intellikine, Inc. Heterocyclic kinase inhibitors
WO2010059836A1 (en) * 2008-11-20 2010-05-27 Decode Genetics Ehf Substituted aza-bridged bicyclics for cardiovascular and cns disease
RU2624506C2 (ru) 2009-04-29 2017-07-04 АМАРИН КОРПОРЕЙШН ПиЭлСи Фармацевтические композиции, содержащие ера и сердечно-сосудистое средство, и способы их применения
WO2011133229A2 (en) * 2010-04-23 2011-10-27 Steam Tech, Llc Surface wiper system
CA2799926A1 (en) * 2010-05-28 2011-12-01 Biocryst Pharmaceuticals, Inc. Heterocyclic compounds as janus kinase inhibitors
RS54834B1 (sr) 2010-09-07 2016-10-31 Astellas Pharma Inc Jedinjenja pirazolokvinolina
US8637516B2 (en) 2010-09-09 2014-01-28 Irm Llc Compounds and compositions as TRK inhibitors
WO2012034095A1 (en) 2010-09-09 2012-03-15 Irm Llc Compounds and compositions as trk inhibitors
US9034883B2 (en) 2010-11-15 2015-05-19 Boehringer Ingelheim International Gmbh Vasoprotective and cardioprotective antidiabetic therapy
BR112013021638A2 (pt) 2011-02-25 2016-08-02 Irm Llc "compostos inibidores de trk, seu uso e composições que os compreendem"
JP5988941B2 (ja) * 2012-09-20 2016-09-07 富士フイルム株式会社 有機銅錯体、有機銅錯体溶液、銅酸化物薄膜、銅酸化物薄膜の製造方法、および、化合物
US10434132B2 (en) * 2013-06-04 2019-10-08 Academia Sinica Galactolipids-enriched plant extracts and the uses thereof
EP3710005B8 (en) * 2017-11-17 2023-06-14 Academia Sinica SUBSTITUTED PYRROLO[2,1,-ALPHA]PHTHALAZINES AND BENZO[g]PYRROL[2,1,-ALPHA]PHTHALAZINES AND THEIR USES IN THE TREATMENT OF CANCER
CA3116506C (en) * 2018-10-17 2023-08-01 Suven Life Sciences Limited Pyrrolo-pyridazine derivatives as muscarinic m1 receptor positive allosteric modulators
CN113825543A (zh) 2019-03-19 2021-12-21 勃林格殷格翰动物保健美国公司 驱虫的氮杂-苯并噻吩和氮杂-苯并呋喃化合物
MX2022015038A (es) 2020-05-29 2023-01-04 Boehringer Ingelheim Animal Health Usa Inc Compuestos heterociclicos como anthelminticos.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06501918A (ja) * 1990-05-25 1994-03-03 藤沢薬品工業株式会社 ピロロピリダジン化合物
EP1085021A4 (en) 1998-05-21 2003-01-08 Shionogi & Co DERIVATIVES OF PYRROLO 1,2-B] PYRIDAZINE, WITH INHIBITOR EFFECT ON SPLA 2?
IT1303272B1 (it) * 1998-10-29 2000-11-06 Zambon Spa Derivati triciclici inibitori della fosfodiesterasi 4
FR2792938B1 (fr) * 1999-04-28 2001-07-06 Warner Lambert Co NOUVELLES 1-AMINO TRIAZOLO [4,3-a] QUINAZOLINE-5-ONES INHIBITRICES DE PHOSPHODIESTERASES IV
DE60136530D1 (de) * 2000-03-01 2008-12-24 Janssen Pharmaceutica Nv 2,4-disubstituierte thiazolyl derivate
AU2001267823A1 (en) * 2000-06-29 2002-01-08 Shionogi And Co., Ltd. Compounds exhibiting x-type spla2 inhibiting effect
CA2429628A1 (en) * 2000-11-17 2002-05-23 Bristol-Myers Squibb Company Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors
TWI312347B (en) * 2001-02-08 2009-07-21 Eisai R&D Man Co Ltd Bicyclic nitrogen-containing condensed ring compounds
EP1426050A4 (en) * 2001-08-23 2005-05-25 Takeda Pharmaceutical INHIBITORS OF JNK
US6900208B2 (en) * 2002-03-28 2005-05-31 Bristol Myers Squibb Company Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders
PL378245A1 (pl) 2003-01-09 2006-03-20 Astellas Pharma Inc. Pochodne pirolopirydazyny

Also Published As

Publication number Publication date
CA2513081A1 (en) 2004-07-29
ES2291729T7 (es) 2010-03-31
EP1581535B3 (en) 2009-09-02
ES2291729T3 (es) 2008-03-01
US20060270678A1 (en) 2006-11-30
NZ541232A (en) 2008-02-29
EP1581535B9 (en) 2008-03-19
EP1581535B1 (en) 2007-10-24
KR20050092738A (ko) 2005-09-22
PT1581535E (pt) 2007-12-12
NO20053748L (no) 2005-10-07
ATE376549T1 (de) 2007-11-15
CY1107084T1 (el) 2012-10-24
WO2004063197A1 (en) 2004-07-29
DK1581535T5 (da) 2009-12-21
TW200418861A (en) 2004-10-01
PL378245A1 (pl) 2006-03-20
DK1581535T3 (da) 2008-02-11
TWI332004B (en) 2010-10-21
DE60317102D1 (de) 2007-12-06
EP1581535A1 (en) 2005-10-05
US7153854B2 (en) 2006-12-26
IL169500A0 (en) 2007-07-04
US20050075342A1 (en) 2005-04-07
US7317009B2 (en) 2008-01-08
DE60317102T3 (de) 2010-02-18
KR101026819B1 (ko) 2011-04-04
RU2328499C2 (ru) 2008-07-10
JP2006515597A (ja) 2006-06-01
RU2005125209A (ru) 2006-01-27
AR042833A1 (es) 2005-07-06
BR0317358A (pt) 2005-12-13
DE60317102T2 (de) 2009-01-29
HK1088900A1 (en) 2006-11-17
NO20053748D0 (no) 2005-08-04
JP4671104B2 (ja) 2011-04-13
CA2513081C (en) 2011-04-19

Similar Documents

Publication Publication Date Title
MXPA05007462A (es) Derivados de pirrolopiridazina.
TW200606162A (en) Pyrazolopyridine derivatives
UA98961C2 (uk) Похідні піразинону та їх застосування у лікуванні легеневих захворювань
WO2005013892A3 (en) Hydrolytically-resistant boron-containing therapeutics and methods of use
TW200500358A (en) Compounds
MXPA05012061A (es) Preparacion y uso de derivados alquilarilo para el tratamiento de la obesidad.
GEP20084551B (en) 4-phenylamino-quinazolin-6-yl-amides
TW200724543A (en) Heterocyclic compounds and their uses as therapeutic agents
GB0305152D0 (en) Organic compounds
EP1633740A4 (en) CHEMICAL COMPOUNDS
TW200621262A (en) New dihydropteridione derivatives, process for their manufacture and their use as medicament
MXPA05010712A (es) Derivados de quinolin-2-ona para el tratamiento de enfermedades de las vias respiratorias.
EA200700501A1 (ru) Композиция (варианты) и способ для лечения гиперпролиферативных процессов, способ лечения рака (варианты) и способ получения твёрдой дисперсии вещества
MX2007002398A (es) Nuevas composiciones farmaceuticas para el tratamiento de cancer.
TW200716546A (en) Oxindole compounds and their uses as therapeutic agents
WO2005110994A3 (en) Substituted pyrazolyl urea derivatives useful in the treatment of cancer
TW200724537A (en) Pyrimidine derivatives for treatment of hyperproliferative disorders
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
EA200601212A1 (ru) Ингибиторы фосфодиэстеразы, получение и их терапевтическое применение
TW200630374A (en) Thiazolyldihydroindazoles
TW200626553A (en) Novel compounds
MY135850A (en) Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use
TW200517389A (en) Biaryloxymethylarenecarboxylic acids
EP1817312A4 (en) MACROCYCLIC AMINIOPYRIDYL BETA SEKRETASE INHIBITORS FOR THE TREATMENT OF MORBUS ALZHEIMER
UA104988C2 (uk) Похідні піроніндолу та спосіб їх отримання

Legal Events

Date Code Title Description
FG Grant or registration